“…However, findings are contradictory. Some of these studies indicated the association of CCDN1 G870A with cancer risk, prognosis, survival or characteristics of tumors such as larynx and oral cavity (Izzo, 2003), nonsmall lung cancer (Betticher et al, 1995), breast cancer (Yaylim-Eraltan et al, 2009), head and neck cancer (Zheng et al, 2001), ovarian cancer (Dhar et al, 1999), pituitary adenomas (Simpson et al, 2001). A meta-analysis which also includes our previous study (Yaylim-Eraltan et al, 2010), reported a significant association between colorectal cancer risk and G870A polymorphism.…”